carvedilol 6.25 mg
1 INDICATIONS AND USAGE Carvedilol is an alpha-/beta-adrenergic blocking agent indicated for the treatment of: mild to severe chronic heart failure ( 1.1 ) left ventricular dysfunction following myocardial infarction in clinically stable patients ( 1.2 ) hypertension ( 1.3 ) 1.1 Heart Failure Carvedilol is indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [see Drug Interactions ( 7.4 ), Clinical Studies ( 14.1 )] . 1.2 Left Ventricular Dysfunction following Myocardial Infarction Carvedilol is indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40% (with or without symptomatic heart failure) [see Clinical Studies ( 14.2 )] . 1.3 Hypertension Carvedilol is indicated for the management of essential hypertension [see Clinical Studies ( 14.3 , 14.4 )] . It can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics [see Drug Interactions ( 7.2 )] .
advagen pharma ltd
OVAL WHITE A56
A56 OVAL WHITE
Related Pills
carvedilol 3.125 mg
advagen pharma ltd
carvedilol 12.5 mg
Advagen Pharma Ltd
carvedilol 25 mg
advagen pharma ltd
sucralfate tablet
amneal pharmaceuticals ny llc
etravirine tablet 25 mg
amneal pharmaceuticals ny llc
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
CARVEDILOL tablets, USP are white to off white, oval shaped film coated tablets are available in the following strengths: 3.125 mg β debossed with βΙ βon one side and β55βon other side 6.25 mg β debossed with βΙ 56βon one side and plain on other side 12.5 mg β debossed with βΙ 57βon one side and plain on other side 25 mg β debossed with βΙ 59β on one side and plain on other side The 3.125-mg, 6.25-mg, 12.5-mg, and 25-mg tablets are film coated tablets. 3.125 mg bottles of 30: NDC 72888-034-30 3.125 mg bottles of 100: NDC 72888-034-01 3.125 mg bottles of 500: NDC 72888-034-05 3.125 mg bottles of 1000: NDC 72888-034-00 6.25 mg bottles of 30: NDC 72888-035-30 6.25 mg bottles of 100: NDC 72888-035-01 6.25 mg bottles of 500: NDC 72888-035-05 6.25 mg bottles of 1000: NDC 72888-035-00 12.5 mg bottles of 30: NDC 72888-036-30 12.5 mg bottles of 100: NDC 72888-036-01 12.5 mg bottles of 500: NDC 72888-036-05 12.5 mg bottles of 1000: NDC 72888-036-00 25 mg bottles of 30: NDC 72888-037-30 25 mg bottles of 100: NDC 72888-037-01 25 mg bottles of 500: NDC 72888-037-05 25 mg bottles of 1000: NDC 72888-037-00 Store below 30Β°C (86Β°F). Protect from moisture. Dispense in a tight, light-resistant container.
More pills like OVAL A56